The combination of brinzolamide and timolol is used to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Brinzolamide is a carbonic anhydrase inhibitor that decreases the production of intraocular fluid, while timolol is a beta-blocker that lowers pressure by reducing fluid production.
The medication is administered as eye drops, usually twice daily, as directed by a doctor. It is important for patients to follow the treatment regimen to prevent vision deterioration.
Common side effects include a burning or stinging sensation in the eyes, dry eyes, headache, and fatigue. In rare cases, allergic reactions or breathing difficulties may occur.
This combination is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about any other conditions or medications being used to avoid drug interactions.
General data about AICYBET 10mg/ml+5mg/ml 10mg / 5mg / ml
Substance:
brinzolamide + timolol
Date of latest medicines list:
01-11-2026
Product code:
W72265001
Strength:
10mg / 5mg / ml
Pharmaceutical form:
ophthalmic drops suspension
Quantity:
1
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Marketing authorisation
Manufacturer:
TUBILUX PHARMA S.P.A - ITALIA
Holder:
OMNIVISION GMBH - GERMANIA
Number:
16930/2026/01
Shelf life:
2 years-after packaging for sale;after the first opening of the bottle-2 months
Other substances similar to brinzolamide + timolol